Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vicore Pharma Holding

10.72 SEK-2.37 %13.11, 17.29
Less than 1K followers

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-2.37 %
+20.99 %
-8.22 %
-4.96 %
-5.13 %
+5.10 %
-16.53 %
-35.27 %
+112.28 %

Vicore Pharma Holding operates in the pharmaceutical industry and focuses on the development of innovative treatments for pulmonary and cardiovascular diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Vicore Pharma was founded in 2000 and is headquartered in Gothenburg, Sweden.

Read more
Market cap
3.02B SEK
Turnover
9.69M SEK
Revenue
3.82M
EBIT %
-11,851.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25.2
2027

Annual report '26

5.5
2027

General meeting '27

5.5
2027

Interim report Q1'27

Press release10.11.2026, 08.00

Vicore Pharma to Participate in the Jefferies Global Healthcare Conference

Vicore Pharma Holding
Regulatory press release05.11.2026, 08.00

Vicore Pharma Announces Third Quarter 2026 Financial Results and Provides Business Update

Vicore Pharma Holding
Regulatory press release03.11.2026, 08.00

Vicore Announces the Nomination Committee for the 2027 Annual General Meeting

Vicore Pharma Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release02.11.2026, 08.00

Vicore Pharma to Participate in the Guggenheim Annual Healthcare Innovation Conference and the Stifel Healthcare Conference

Vicore Pharma Holding
Regulatory press release22.10.2026, 18.50

Vicore’s Phase 2b ASPIRE Trial of Buloxibutid in IPF Passes Pre-Planned Futility Analysis and Remains on Track for Mid-2027 Topline Results

Vicore Pharma Holding
Press release13.10.2026, 08.00

Vicore Pharma to Participate in the Chardan Healthcare Conference

Vicore Pharma Holding
Regulatory press release30.09.2026, 09.00

Increase in number of shares and votes in Vicore Pharma

Vicore Pharma Holding
Press release17.09.2026, 08.00

Vicore Pharma to Present in the Stifel 2026 Virtual Immunology and Inflammation Forum

Vicore Pharma Holding
Press release01.09.2026, 08.00

Vicore Pharma to Participate in Upcoming Healthcare Conferences

Vicore Pharma Holding
Press release26.08.2026, 08.00

Vicore Pharma to Present at the Pareto Securities 17th Annual Healthcare Conference

Vicore Pharma Holding
Press release24.08.2026, 08.00

Vicore Pharma to Present at the European Respiratory Society Congress 2026

Vicore Pharma Holding
Regulatory press release21.08.2026, 08.00

Interim Report April – June 2026

Vicore Pharma Holding
Press release07.07.2026, 08.00

Vicore Pharma to Participate in the Leerink Therapeutics Forum

Vicore Pharma Holding
Press release06.07.2026, 08.00

Vicore Pharma Appoints Rob Slack as Chief Scientific Officer

Vicore Pharma Holding
Press release01.07.2026, 22.01

Vicore Pharma to Commence Trading in the United States on The Nasdaq Stock Market

Vicore Pharma Holding
Press release02.06.2026, 08.00

Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape

Vicore Pharma Holding
Press release26.05.2026, 08.00

Vicore Pharma to Present at the Jefferies Global Healthcare Conference

Vicore Pharma Holding
Press release22.05.2026, 14.38

Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC

Vicore Pharma Holding
Press release07.05.2026, 08.00

Vicore Pharma Elects Peter Guenter to its Board of Directors

Vicore Pharma Holding
Regulatory press release06.05.2026, 16.30

Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)

Vicore Pharma Holding